Testing for the classic hereditary breast cancer genes, BRCA1 and BRCA2, has been available and widely offered since their discovery in the 1990s. However, new technologies in genetic testing have recently uncovered information about other genes linked to hereditary breast cancer. In this presentation by the Mass General Blum Center, join Carly Grant, MS, LCGC, to learn about other hereditary breast cancer genes beyond BRCA1 and BRCA2.
Genetic testing for cancer risk assessment was first offered in 1996 for a limited number of genes. Many people have heard of the BRCA genes, but cancer genetics has changed significantly since 1996. Stephanie Hicks, MS, LCGC, shares more about the role of genetic testing in the cancer setting.
Learn more about the Blum Center
Learn more about resources and upcoming events from the Blum Center